Viracta Therapeutics Inc (STU:RYIS)
€ 0.645 -0.015 (-2.27%) Market Cap: 26.70 Mil Enterprise Value: 12.59 Mil PE Ratio: 0 PB Ratio: 5.14 GF Score: 40/100